• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Tan Daniel

    11/25/22 4:05:50 PM ET
    $LAX
    Get the next $LAX alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Tan Daniel

    (Last) (First) (Middle)
    C/O EUDA HEALTH HOLDINGS LIMITED,
    1 PEMIMPIN DRIVE #02-02 ONE PEMIMPIN

    (Street)
    SINGAPORE 576152

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    11/17/2022
    3. Issuer Name and Ticker or Trading Symbol
    EUDA Health Holdings Ltd [ EUDA ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CHIEF TECHNOLOGY OFFICER
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Daniel Tan 11/25/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAX
    SEC Filings

    View All

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/22/24 9:30:30 PM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/17/24 6:10:06 AM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    12/29/23 5:03:20 PM ET
    $LAX

    $LAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/20/23 3:19:26 PM ET
    $LAX

    SEC Form 3: New insider Wong Kongyew claimed no ownership of stock in the company

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/8/23 8:31:59 PM ET
    $LAX

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    5/26/23 8:42:17 AM ET
    $LAX

    $LAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination

    Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Ltd ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" (NASDAQ:EUDA) and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on N

    11/23/22 4:32:15 PM ET
    $LAX

    8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination

    Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Limited ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on November 18, 202

    11/17/22 5:23:47 PM ET
    $LAX

    8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption

    Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ:LAX, the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company's business combination with EUDA Health Limited were approved by shareholders. Holders of Company's ordinary shares that elected to redeem shares in connection with the Company's special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in

    11/10/22 4:01:00 PM ET
    $LAX

    $LAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13D/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    5/26/23 8:44:16 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/14/23 10:13:57 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/7/23 4:59:19 PM ET
    $LAX